Skip to main content
. 2020 May 27;201(2):200–204. doi: 10.1111/cei.13451

Fig. 2.

Fig. 2

Receiver operating characteristic (ROC) curve for the model predicting LDA/remission at 6 months of apremilast treatment. Low baseline DAPSA and high sCD40L serum levels at the start of apremilast predict 6‐month clinical response. Variables left in the model: baseline DAPSA [odds ratio (OR) = 0·80 per single unit, 95% confidence interval (CI) = 0·65–0·98] and baseline soluble CD40L level (OR = 1·001 per single unit, 95% CI = 1·0001–1·0028). Area under the curve = 0·85 (95% CI = 0·69–0·98). DAPSA = disease activity in psoriatic arthritis; LDA = low disease activity.